JNJ-40411813

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for JNJ-40411813, covering 2013-07-09 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy [Phase 2]